Bioengineered EVs enriched with therapeutic microRNAs (e.g., miR-181a-5p, miR-146a-5p) or proteins (e.g., PD-L1) further improved bacterial clearance and mitigated cytokine storms in severe infection models (31, 32, 36, 37). This evidence concerns the gene CD274 and infection.